DNA methylation age is not accelerated in brain or blood of subjects with schizophrenia

Individuals with schizophrenia (SZ) exhibit multiple premature age-related phenotypes and die ~20years prematurely. The accelerated aging hypothesis of SZ has been advanced to explain these observations, it posits that SZ-associated factors accelerate the progressive biological changes associated with normal aging. Testing the hypothesis has been limited by the absence of robust, meaningful, and multi-tissue measures of biological age. Recently, a method was described in which DNA methylation (DNAm) levels at 353 genomic sites are used to produce "DNAm age", an estimate of biological age with advantages over existing measures. We used this method and 3 publicly-available DNAm datasets, 1 from brain and 2 from blood, to test the hypothesis. The brain dataset was composed of data from the dorsolateral prefrontal cortex of 232 non-psychiatric control (NPC) and 195 SZ subjects. Blood dataset #1 was composed of data from whole blood of 304 NPC and 332 SZ subjects, and blood dataset #2 was composed of data from whole blood of 405 NPC and 260 SZ subjects. DNAm age and chronological age correlated strongly (r=0.92-0.95, p<0.0001) in both NPC and SZ subjects in all 3 datasets. DNAm age acceleration did not differ between NPC and SZ subjects in the brain dataset (t=0.52, p=0.60), blood dataset #1 (t=1.51, p=0.13), or blood dataset #2 (t=0.93, p=0.35). Consistent with our previous findings from a smaller study of postmortem brains, our findings suggest there is no acceleration of brain or blood aging in SZ and, thus, do not support the accelerated aging hypothesis of SZ.

[1]  B. Kirkpatrick,et al.  Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naïve patients with nonaffective psychosis , 2017, Schizophrenia Research.

[2]  J. Kleinman,et al.  Reliability of psychiatric diagnosis in postmortem research , 2005, Biological Psychiatry.

[3]  Robin M. Murray,et al.  An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation , 2016, Genome Biology.

[4]  S. Thiagalingam,et al.  Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post‐mortem brain of patients with schizophrenia and Psychotic bipolar disorder , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[5]  S. Horvath,et al.  DNA methylation age of blood predicts all-cause mortality in later life , 2015, Genome Biology.

[6]  D. Jeste,et al.  Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. , 2011, Schizophrenia bulletin.

[7]  Steve Horvath,et al.  Accelerated epigenetic aging in Down syndrome , 2015, Aging cell.

[8]  O. Okusaga.  Accelerated aging in schizophrenia patients: the potential role of oxidative stress. , 2014, Aging and disease.

[9]  S. Saha,et al.  A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? , 2007, Archives of general psychiatry.

[10]  M. First,et al.  Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .

[11]  I. Nazareth,et al.  Physical activity, dietary habits and Coronary Heart Disease risk factor knowledge amongst people with severe mental illness , 2007, Social Psychiatry and Psychiatric Epidemiology.

[12]  Etienne Sibille,et al.  Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphism , 2011, Neurobiology of Disease.

[13]  J. Kleinman,et al.  Critical Factors in Gene Expression in Postmortem Human Brain: Focus on Studies in Schizophrenia , 2006, Biological Psychiatry.

[14]  P. Pan,et al.  Shorter leukocyte telomere length in patients at ultra high risk for psychosis , 2017, European Neuropsychopharmacology.

[15]  S. Horvath,et al.  HIV-1 Infection Accelerates Age According to the Epigenetic Clock , 2015, The Journal of infectious diseases.

[16]  M. Heo,et al.  The distribution of body mass index among individuals with and without schizophrenia. , 1999, The Journal of clinical psychiatry.

[17]  R. Sweet,et al.  Dendritic spine alterations in schizophrenia , 2015, Neuroscience Letters.

[18]  B. Laufer,et al.  DNA methylation in psychosis: insights into etiology and treatment. , 2015, Epigenomics.

[19]  Philip D. Harvey,et al.  Is schizophrenia a syndrome of accelerated aging? , 2008, Schizophrenia bulletin.

[20]  O. Wolkowitz,et al.  Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging , 2015, Neuroscience & Biobehavioral Reviews.

[21]  Daniel R Weinberger,et al.  Mapping DNA methylation across development, genotype, and schizophrenia in the human frontal cortex , 2015, Nature Neuroscience.

[22]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[23]  Wei Zhang,et al.  Reduced Dendritic Spine Density in Auditory Cortex of Subjects with Schizophrenia , 2009, Neuropsychopharmacology.

[24]  S. Horvath,et al.  Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels , 2016, Aging.

[25]  P. Mortensen,et al.  Excess early mortality in schizophrenia. , 2014, Annual review of clinical psychology.

[26]  T. Prolla.  Multiple roads to the aging phenotype: insights from the molecular dissection of progerias through DNA microarray analysis , 2005, Mechanisms of Ageing and Development.

[27]  Andres Metspalu,et al.  The transcriptional landscape of age in human peripheral blood , 2015, Nature Communications.

[28]  David A Lewis,et al.  Schizophrenia as a disorder of neurodevelopment. , 2002, Annual review of neuroscience.

[29]  R. Marioni,et al.  The epigenetic clock and telomere length are independently associated with chronological age and mortality , 2016, International journal of epidemiology.

[30]  H. Kraemer,et al.  Elevated plasma F2-isoprostane levels in schizophrenia , 2016, Schizophrenia Research.

[31]  D. Jeste,et al.  Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables. , 2017, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[32]  A. Sampson,et al.  Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia , 2015, Biological Psychiatry.

[33]  O. Howes,et al.  Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis , 2017, JAMA psychiatry.

[34]  C. Crombie,et al.  A threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophrenia , 2010, Molecular Psychiatry.

[35]  A. Farmer,et al.  A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. , 1991, Archives of general psychiatry.

[36]  J. Endicott,et al.  Schedule for Affective Disorders and Schizophrenia , 2014 .

[37]  D. Lewis,et al.  Dendritic spine pathology in schizophrenia , 2013, Neuroscience.

[38]  H. Kraemer,et al.  Leukocyte telomere length: Effects of schizophrenia, age, and gender. , 2017, Journal of psychiatric research.

[39]  P. Fitzgerald,et al.  Superior temporal gyrus volume change in schizophrenia: A review on Region of Interest volumetric studies , 2009, Brain Research Reviews.

[40]  M. Levine,et al.  DNA methylation-based measures of biological age: meta-analysis predicting time to death , 2016, Aging.

[41]  J. Birtwistle,et al.  The unhealthy lifestyle of people with schizophrenia , 1999, Psychological Medicine.

[42]  S. Horvath,et al.  Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring , 2015, Aging.

[43]  Evgeny Putin,et al.  Deep biomarkers of human aging: Application of deep neural networks to biomarker development , 2016, Aging.

[44]  P. Visscher,et al.  Rare chromosomal deletions and duplications increase risk of schizophrenia , 2008, Nature.

[45]  J. Mill,et al.  Schizophrenia-associated methylomic variation: molecular signatures of disease and polygenic risk burden across multiple brain regions , 2016, Human molecular genetics.

[46]  O. Wolkowitz,et al.  The Association Between Psychiatric Disorders and Telomere Length: A Meta-Analysis Involving 14,827 Persons , 2016, Psychosomatic medicine.

[47]  M. Pato,et al.  Using consensus OPCRIT diagnoses , 1999, British Journal of Psychiatry.

[48]  D. Henderson,et al.  Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. , 2015, The lancet. Psychiatry.

[49]  Alan C. Evans,et al.  Changes in cortical thickness during the course of illness in schizophrenia. , 2011, Archives of general psychiatry.